News

Sanwa will use these customized ES cell assays to identify and screen new diabetes drug candidates. The assay systems were developed to expand the capabilities of VistaGen’s ES

Under the terms of the binding letter of intent, NeoPharm and Siro have agreed to negotiate in good faith the terms of a clinical research agreement pursuant to

Bill Worthen, president and CEO of Alsius, said: “This is the fourth contract we have been awarded by a major hospital group purchasing organization in the US. We

Dr Odlaug served as executive vice president and a member of the senior management committee at Fujisawa Healthcare until its merger with Yamanouchi in 2005, which resulted in

The results showed the efficacy of the Cooled ThermoCath (CTC) microwave catheter is durable for at least five years and the freedom from additional minimally invasive or surgical

The state-of-the-art facility produces Edwards’s Carpentier-Edwards Perimount tissue heart valve replacements, and also serves as the headquarters for Edwards’s Asia-Pacific operations. Donald Bobo, Jr, corporate vice president of

The therapeutic areas included in these awards are oncology, asthma, diabetes, rheumatology, and immunology or vaccines. Services to be provided include consulting, regulatory affairs, project management, field monitoring,

Indevus jointly granted the rights along with Rottapharm Madaus Group, an Italian pharmaceutical group, as required by a prior agreement between Indevus and Rottapharm Madaus. Indevus and Rottapharm

The company has also received renewed research funding from the National Institutes of Health (NIH) to continue preclinical development of severe acute respiratory syndrome (SARS) vaccine candidates using